Arlington Aging Study

This observational study, called the Arlington Aging Study, aims to understand how aging affects our bodies and minds. Researchers are looking at how factors like race, ethnicity, and sex influence aging and its impact on health and disease. They will use various methods, including imaging, exercise science, and remote monitoring, to learn more about the biology of aging. The study is open to healthy men and women aged 18-30 years, and older men and women aged 50-85 years, particularly those living in Tarrant County, Texas. Success in this study means advancing our knowledge of aging and its effects on health.

Study design
This is an observational study with a planned enrollment of 770 participants. It is not a drug trial, but rather aims to understand the mechanisms of aging.
What's involved
You would participate in two study visits, each lasting up to 5 hours. These visits involve questionnaires, blood pressure measurements, exercise capacity tests, cognitive function tests, smell tests, blood draws, and other physical assessments.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06857877

Arlington Aging Study

Recruiting
Not specifiedAges 18–85Observational
The University of Texas at Arlington
~770 participants
Updated 2026-04-23 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sense of Smell
Measured over Baseline
+28 more outcomes measured
Aging

NCT06857877

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Texas Arlington

    Arlington, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

  • Sense of SmellBaseline

    Olfactory Testing will be assessed using the NIH Toolbox Odor Identification cards. After scratching a card and sniffing from each sample, respondents will be asked to choose the best match for each odor from pictures representing the odor sources.

  • Blood PressureBaseline

    Blood Pressure will be measured in the sitting position using an automated blood pressure monitor. After sitting blood pressure measurements, participants will be asked to stand up to measure standing blood pressure.

  • Street AddressBaseline

    Geographic information systems will assign a geocode to each participant's home address, providing latitude, and longitude coordinates based on the provided street address.

  • Ankle Brachial IndexBaseline

    The Ankle Brachial Index will be noninvasively assessed using the Smartdop XT device (Koven Technology, Inc.).

  • Pulse Wave VelocityBaseline

    Arterial stiffness will be measured non-invasively with the Sphygmocor XCEL device (AtCor Medical).

  • Flow- mediated dilationBaseline

    The flow-mediated change in brachial artery diameter (i.e. flow-mediated dilation; FMD), in response to a 5-minute period of arterial occlusion will be used to assess peripheral vascular function.

  • Steps takenBaseline

    A wrist-worn continuous activity tracker (Fitbit wristband) will be worn by the subjects for 7 days.

  • Sedentary TimeBaseline

    A wrist-worn continuous activity tracker with heart rate monitor (Fitbit wristband) will be worn by the subjects for 7 days.

  • SleepBaseline

    A wrist-worn continuous activity tracker (Fitbit) will be worn by the subjects for 7 days to assess total sleep time, and sleep quality.

  • Medical History QuestionnaireBaseline

    Participants will complete health history questionnaires to gain a deeper understanding of their lived experiences and past medical history.

  • Complete blood countBaseline

    Venous blood will be drawn by a trained phlebotomist and/or nurse in the fasting state. Blood will be shipped to LabCorp for processing of the complete blood count.

  • Functional MobilityBaseline

    Objective gait measurements will be obtained using a gait mat. Participants will complete 6 separate walks down the full length of the walkway; 3 walks at a preferred pace and 3 walks while performing different secondary tasks (i.e. dual-task gait) in a fixed order: 1. counting backward by ones, 2. naming animals, and 3. counting backward by sevens. Walking aids will be permitted.

  • Cognitive FunctionBaseline

    Cognitive function will be assessed using the NIH Toolbox Cognition Battery (NIHTB-CB), administered on an iPad or computer by a trained study team member.

  • Lower extremity functionBaseline

    Participants will perform the Short Physical Performance Battery (SPPB). The test includes walking, the sit-to-stand test and balance.

  • Grip strengthBaseline

    Grip strength will be measured following a standardized approach using a validated Jamar handgrip dynamometer (Model J00105, JAMAR Hydraulic Hand Dynamometer).

  • Bone DensityBaseline

    Participants will undergo Dual X-Ray Absorbency (DEXA) to measure bone density.

  • Interstitial glucoseBaseline

    A continuous glucose monitor that measures interstitial glucose will be worn by the subject for 7 days.

  • Body CompositionBaseline

    Participants will undergo Dual X-Ray Absorbency (DEXA) to measure subcutaneous and visceral fat content.

  • Ambulatory blood pressureBaseline

    A wrist worn continuous blood pressure monitor (Aktiia wristband) will be worn by the subjects for 7 days for the measurement of ambulatory blood pressure.

  • Exercise CapacityBaseline

    Exercise Capacity will be assessed using the six-minute walk test.

  • Blood lipidsBaseline

    Venous blood will be drawn and shipped to Labcorp for blood lipid analysis

  • Metabolic Panel (blood)Baseline

    Venous blood will be drawn and shipped to labcorp for evaluation of the metabolic panel.

  • Apolipoprotein ABaseline

    Measured by labcrop from venous blood draw.

  • Apolipoprotein BBaseline

    Analyzed by labcorp from venous blood draw.

  • Lipoprotein ABaseline

    Analyzed by labcorp from venous blood draw

  • Blood checmistry panelBaseline

    Analyzed by labcorp from venous blood draw

  • HbA1C (blood)Baseline

    Analyzed by labcorp from venous blood draw

  • High sensitivity C reactive protein (blood)Baseline

    Analyzed by labcorp from venous blood draw

  • Genetic testingBaseline

    Whole blood (approximately 25 ml) will be stored in special tubes that preserve genetic material in our -80ºC freezer. Genetic testing experiments, including targeted single variants, single gene testing, genetic panel testing, whole genome sequencing, chromosomal testing, gene expression and biochemical testing, may be performed on the samples.